lerapolturev
istari
['melanoma']
istari will continue enrolling patients to the enhanced dosing regimen with confirmatory data expected in q2 2023. #smr #societyformelanomaresearch #2022congress #melanoma #lerapolturev #clinicalresearch 
Istari Oncology is a clinical-stage biotechnology company developing novel immunotherapies for the treatment of solid tumors.